Reumatizam, Vol. 55 No. 2, 2008.
Izlaganje sa skupa
Stabile remission of early active rheumatoid arthritis treated with etanercept (Enbrel®)
Dušanka Martinović Kaliterna
; Odsjek za kliničku imunologiju i reumatologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split, Split, Hrvatska
Sažetak
Regarding to the role of cytokines in ethiology of rheumatoid arthritis, the treatment with anti-TNFα is coming to be reasonable in early aggressive rheumatoid arthritis. Studies of etanercept in early stage of disease indicate the sustained efficacy and decreased rate of radiographic progression with signifficant improvement of life quality.
Ključne riječi
rheumatoid arthritis; anti-TNFα; etanercept
Hrčak ID:
125247
URI
Datum izdavanja:
17.10.2008.
Posjeta: 744 *